ATP13A2の喪失によるリソソームポリアミンの蓄積は,リソソームのpHと静電ヒドロラゼ-脂質相互作用によってβ-グルコセブロシダスを損なう
Madhuja Samaddar1, Gabriel A Fitzgerald1, Ann Hong Nguyen1
1Denali Therapeutics, Inc., South San Francisco, CA 94080, USA.
Cell reports
|August 23, 2025
まとめ
ATP13A2変異によるライソソームポリアミンの蓄積は酵素機能を損なっており,パーキンソン病 (PD) などの神経変性疾患に寄与する. リゾソームのpHまたはビス・モノ・グリセロ・フォスファート (BMP) のレベルを回復することで,この損傷を逆転させることができます.
科学分野:
- 細胞生物学
- 神経科学
- 生物化学
背景:
- ATP13A2変異は,パーキンソン病 (PD) などのリソソーム欠陥を持つ神経変性疾患と関連しています.
- リソソーム機能におけるポリアミンの正確な役割と,疾患の病原性への影響は不明である.
- ポリアミンは様々な細胞機能を持つ不可欠な分子ですが,その蓄積は細胞ホメオスタシスを破壊します.
研究 の 目的:
- ATP13A2欠乏したモデルにおけるリゾソーマのポリアミン蓄積の影響を調査する.
- ポリアミンが溶解体機能と酵素活性に影響を与える分子機構を明らかにする.
- ポリアミン関連性溶解体機能障害に対する潜在的な治療戦略を探求する.
主な方法:
- ATP13A2 ノックアウト (KO) 細胞系とヒト誘発多能幹細胞 (iPSC) 派生ニューロンを利用した.
- 分析されたリソソームポリアミンとビス・モノアシルグリセロフォスファート (BMP) レベル.
- KOモデルと in vitro 試験で評価されたβ-グルコセブレブロジダース (GCase) 活性と基質レベル.
- GCaseの活性に対するリゾソーム再酸化とBMP補給の影響を調査した.
主要な成果:
- ATP13A2KO細胞とニューロンにおける重要なリゾソームポリアミンの蓄積が示された.
- Atp13a2KO脳におけるBMPの二次貯蔵とグルコシルシンゴシンの増加を観察した.
- ポリアミンの蓄積は,リゾソームのGCASE活性を抑制し,再酸性化またはBMPによって逆転することが示された.
- ポリアミン誘発のGCASE阻害のpH独立の電気静的メカニズムをリポソームベースの測定で特定した.
結論:
- 過剰なリソソームポリアミンは,GCase活性にとって重要なpHと静電相互作用を乱すことでリソソーム機能を損なう.
- これらの発見は,ATP13A2に関連した神経変性における病原性メカニズムを明らかにし,PDに関連する経路との収束を示唆する.
- ポリアミンのレベルをターゲットにしたり,リゾソームのBMPホメオスタシスを回復したりすることで,関連するリゾソーム貯蔵障害の治療方法が提供される可能性があります.
さらに関連する動画
関連する概念動画
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
ATP Synthase: Mechanism
15.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.1K
The Proteasome
1.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.1K
Inborn Errors of Metabolism
241
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
241
Protein Import into the Peroxisomes
3.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.6K


